THYROCARE TECHNOLOGIES
|
THYROCARE TECHNOLOGIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 12.45 | 33.28 | 21.14 | 16.75 | 16.15 |
| CEPS(Rs) | 19.47 | 39.70 | 27.13 | 22.67 | 20.98 |
| DPS(Rs) | 18.00 | 15.00 | 25.00 | 5.00 | 20.00 |
| Book NAV/Share(Rs) | 100.09 | 98.89 | 80.26 | 68.68 | 81.69 |
| Tax Rate(%) | 27.35 | 22.65 | 25.79 | 37.18 | 38.48 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.27 | 40.03 | 34.62 | 39.97 | 38.26 |
| EBIT Margin(%) | 17.74 | 39.22 | 31.00 | 32.64 | 34.28 |
| Pre Tax Margin(%) | 16.82 | 38.67 | 30.83 | 32.22 | 34.13 |
| PAT Margin (%) | 12.22 | 29.91 | 22.88 | 20.24 | 20.99 |
| Cash Profit Margin (%) | 19.57 | 35.66 | 29.00 | 27.59 | 27.49 |
| Performance Ratios | |||||
| ROA(%) | 7.65 | 25.38 | 22.43 | 18.73 | 17.93 |
| ROE(%) | 12.23 | 37.18 | 28.75 | 22.13 | 19.41 |
| ROCE(%) | 17.61 | 48.42 | 38.51 | 35.14 | 31.36 |
| Asset Turnover(x) | 0.63 | 0.85 | 0.98 | 0.93 | 0.85 |
| Sales/Fixed Asset(x) | 1.19 | 1.49 | 1.36 | 1.22 | 1.17 |
| Working Capital/Sales(x) | 2.69 | 2.87 | 3.40 | 6.15 | 3.49 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.84 | 0.67 | 0.73 | 0.82 | 0.86 |
| Receivable days | 61.79 | 42.73 | 22.50 | 11.96 | 9.83 |
| Inventory Days | 18.09 | 14.84 | 16.23 | 16.26 | 15.91 |
| Payable days | 45.30 | 44.68 | 52.19 | 45.78 | 23.28 |
| Valuation Parameters | |||||
| PER(x) | 34.52 | 23.25 | 42.72 | 29.58 | 32.85 |
| PCE(x) | 22.07 | 19.49 | 33.28 | 21.86 | 25.28 |
| Price/Book(x) | 4.29 | 7.82 | 11.25 | 7.22 | 6.49 |
| Yield(%) | 4.19 | 1.94 | 2.77 | 1.01 | 3.77 |
| EV/Net Sales(x) | 4.26 | 6.93 | 9.62 | 6.01 | 6.93 |
| EV/Core EBITDA(x) | 17.15 | 15.39 | 25.90 | 14.48 | 17.00 |
| EV/EBIT(x) | 24.04 | 17.66 | 31.03 | 18.41 | 20.22 |
| EV/CE(x) | 2.69 | 4.81 | 8.81 | 5.57 | 5.95 |
| M Cap / Sales | 4.32 | 6.95 | 9.65 | 6.03 | 6.95 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -10.56 | 19.05 | 13.90 | 7.78 | 13.08 |
| Core EBITDA Growth(%) | -50.58 | 44.25 | 1.91 | 9.71 | -2.14 |
| EBIT Growth(%) | -59.55 | 50.60 | 8.18 | 2.63 | -5.14 |
| PAT Growth(%) | -63.46 | 55.67 | 28.74 | 3.90 | -9.48 |
| EPS Growth(%) | -62.60 | 57.45 | 26.18 | 3.74 | -7.17 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | 0.01 | 0.01 |
| Current Ratio(x) | 2.30 | 1.95 | 2.53 | 1.86 | 6.61 |
| Quick Ratio(x) | 2.11 | 1.84 | 2.28 | 1.61 | 5.73 |
| Interest Cover(x) | 19.34 | 71.94 | 176.25 | 76.62 | 226.43 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹3,348.5 Cr | -3.1% | 4.3% | 45.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹86,400.2 Cr | -4% | -6.9% | 31.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹79,176.8 Cr | 1.5% | 0% | 77.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹37,886.4 Cr | -2.5% | 6.1% | 177% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹34,101.5 Cr | 1.8% | 5.5% | 69.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹25,542.0 Cr | -2% | -3.4% | 65.4% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -3.1% |
4.3% |
45.2% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
